Bumetanide and Micardis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Micardis (telmisartan). Common drug interactions include macroglossia among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Micardis. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

On Jul, 28, 2026

51 people who take Bumetanide and Micardis together, and have interactions are studied.

Bumetanide and Micardis drug interactions.

What are the common drug interactions of Bumetanide and Micardis, by gender? *:

female:

Macroglossia (large tongue)
Mass
Mastication disorder (disease of chewing food)
Mitral valve calcification (calcium deposit in mitral valve)
Myalgia (muscle pain)
Osteomyelitis (infection of bone)
Osteopenia (a condition where bone mineral density is lower than normal)
Periodontal disease (disease that attacks the gum and bone and around the teeth)
Physical disability
Pulmonary embolism (blockage of the main artery of the lung)

male:

Cardiac failure
Cardiac failure congestive
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pleural effusion (water on the lungs)
Sudden death unexplained
Vision blurred
Abdominal pain upper
Abnormal dreams
Acidosis (build-up of carbon dioxide in the blood)
Activated partial thromboplastin time prolonged

What are the common drug interactions of Bumetanide and Micardis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pancreatitis (inflammation of pancreas)
Papillary thyroid cancer
Post procedural hypothyroidism

40-49:

Chronic kidney disease

50-59:

Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Agitation (state of anxiety or nervous excitement)
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Allergic colitis (inflammation of the colon due to allergy)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Antithrombin iii increased
Arrhythmia supraventricular (irregular heartbeat supraventricular origin)
Arthralgia (joint pain)
Back pain

60+:

Anxiety
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back disorder
Blood creatine phosphokinase increased
Blood immunoglobulin a increased
Bone disorder
Bruxism (habitual grinding of the teeth, typically during sleep)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cardiac disorder

What are the existing conditions these people have? *

Pain: 23 people, 45.10%
Metastases To Bone (cancer spreads to bone): 17 people, 33.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 13.73%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 11.76%
High Blood Cholesterol: 5 people, 9.80%
Infection: 4 people, 7.84%
Diabetes: 4 people, 7.84%
Cardiac Disorder: 4 people, 7.84%
Stress And Anxiety: 3 people, 5.88%
Sleep Disorder: 3 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Micardis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously